No content here.


Introducing “Liquid Biopsy”: The Blood Test That Can Detect 30 Different Types of Cancer

12 May 2022
Clinical 1 Theater

Available for RACE Approved CE credit if watched from 2:00pm-2:50pm CST on Thursday, May 12, 2022.

At its most fundamental level, cancer is caused by abnormalities in DNA. Advances in genomic sequencing technologies now allow for the detection of these abnormalities using a simple blood sample, opening the door to non-invasive cancer identification in dogs. This session will provide a basic overview of cancer biology and introduce the fundamentals of “liquid biopsy” for canine cancer detection using next-generation sequencing of cell-free DNA. A detailed analysis of the clinical validation study of this testing in over 1,000 dogs will be reviewed, along with recent clinical laboratory experience and case examples from real-world veterinary practices.

Angela McCleary-Wheeler, Director - PetDX

Join the Paw-ty!